(Q83177010)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

The role of rituximab in the treatment of canine lymphoma: an ex vivo evaluation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Joseph A Impellizeri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kathy Howell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kathleen P McKeever

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Steven E Crow

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

published in

The Veterinary Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

556-558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

Characterization of lymphocytes in canine gastrointestinal lymphoma

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.03.005

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.03.005

Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.03.005

Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.03.005

Monoclonal antibody-based therapies for hematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.03.005

Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.03.005

10.1016/J.TVJL.2005.03.005

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16624725%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference